Skip to main content
Main navigation
About Us
Leadership
Our People
Memberships
Therapeutic Areas
Infectious Diseases
Oncology
Internal Medicine
CNS & Pain
Respiratory
Services
Translational Medicine
Rare Diseases & Advanced Therapeutics
Medical Affairs
Portfolio Management and Commercial Strategy
Clinical Development and Operations
Regulatory and Peri-registration Activities
Drug Safety, PV and Risk Management
Virtual Offerings and Medical Affairs
Resources
News and Articles
Webinars
Newsletters
Congresses & Events
Brochures
tranScrip Social
Careers
Oncology-Experienced Pharmaceutical Physician
Head of Business Development & Account Management
Senior Medical Writer
Medical Writer
Client Finance & Operational Systems Assistant
Contact Us
Toggle navigation
Main navigation
About Us
Leadership
Our People
Memberships
Therapeutic Areas
Infectious Diseases
Oncology
Internal Medicine
CNS & Pain
Respiratory
Services
Translational Medicine
Rare Diseases & Advanced Therapeutics
Medical Affairs
Portfolio Management and Commercial Strategy
Clinical Development and Operations
Regulatory and Peri-registration Activities
Drug Safety, PV and Risk Management
Virtual Offerings and Medical Affairs
Resources
News and Articles
Webinars
Newsletters
Congresses & Events
Brochures
tranScrip Social
Careers
Contact Us
Apply
tranScrip's Cocktail & Canapé Reception
Pancreatic cancer is a deadly disease with very few new treatments in the past 30 years
tranScrip further strengthen their translation development team
tranScrip's moderated patient session gets top ranking at Future Health Basel!
Carol Burley awarded an Honorary Fellowship of the Institute of Clinical Research (HonFICR) for her services as a member of the Institute’s Board of Directors
Faecal transplants show promise in boosting the efficacy of immunotherapy drugs
tranScrip welcomes Lisa Pearce Collins as Partner
Pharma firms leading the value-based care model must become patient-centric
Can a National Pain Strategy address the dual healthcare crises of chronic pain and prescription opioids?
MHRA Drug Safety Update for the use of fluoroquinolone antibiotics due to adverse side effects